Home
Storia in 2 fonti
FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs
It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to pharmaceutical companies.
- ·
cnbc.com
FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs
It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to pharmaceutical companies.
- ·
upi.com
FDA announces plans to relax rules about copycat drugs - UPI.com
The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.